Which Strategies Will Lead to Progress and Which Will Not? Richard Goldberg
Safety and Efficacy of Panitumumab in the Treatment of Metastatic Colorectal Cancer (mCRC) From Five Clinical Studies Edith Mitchell
Synergistic Effects of Combination Therapy With Anti-EGFR and Anti-Src Therapy in Colorectal Cancer Scott Kopetz
Treatment Effect of Panitumumab versus Best Supportive Care (BSC) in Patients With Metastatic Colorectal Cancer (mCRC): Results of Sensitivity Analyses From a Phase III Randomized Controlled Trial Jennifer Gansert